IFM Investors’s Globus Medical GMED Stock Holding History

IFM Investors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27	Closed	-$2.33K	–	659
2026 Q1	$2.33K	Buy	+27	New	+$2.42K	﹤0.01%	672

Other funds holding GMED

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

IFM Investors's GMED Position: Q2 2026 in Review

IFM Investors sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 27 shares — an estimated $2.33K sold.

IFM Investors first reported a position in GMED in Q1 2026 and held it in 1 quarter. The position peaked at $2.33K in Q1 2026. 129 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

IFM Investors reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
IFM Investors sold 27 Globus Medical shares in Q2 2026, an estimated $2.33K.
IFM Investors first reported a position in Globus Medical in Q1 2026 and held it in 1 quarter.
IFM Investors's Globus Medical position peaked at $2.33K in Q1 2026.
129 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.